📖 Approx. 6 min
With the lack of successors and the aging of clinic directors, an increasing number of clinics and medical corporations are considering closing down and dissolving. However, unlike the liquidation of general commercial corporations (stock companies), the dissolution of a medical corporation is subject to strict regulations specific to the Medical Care Act, such as the requirement for prefectural governor approval and restrictions on the attribution of residual assets. This article provides an expert explanation of the dissolution process for medical corporations, the practical distribution of residual assets depending on the presence of equity interests, tax implications, and a financial comparison between dissolution and healthcare M&A (third-party succession).
Main Statutory Grounds and Legal Requirements for Dissolving a Medical Corporation
In order for a medical corporation to dissolve, it must satisfy the statutory grounds for dissolution stipulated in Article 55 of the Medical Care Act. Even when voluntarily deciding to cease operations, simply closing the clinic does not complete the corporation’s dissolution; administrative procedures and liquidation proceedings must be carried out concurrently.
- Occurrence of dissolution events stipulated in the Articles of Incorporation / Foundation: Expiration of the operational term, etc. (rare in practice).
- Impossibility of accomplishing the designated business purposes: A state where reopening or continuing the clinic is objectively impossible due to the absence of a physician, destruction of buildings, etc. Approval from the prefectural governor is required.
- Resolution of the General Meeting of Members: For an incorporated association (Shadan) medical corporation, a resolution approved by at least three-fourths of all members (unless otherwise specified in the Articles of Incorporation) must be passed and approved by the prefectural governor.
- Decision to commence bankruptcy proceedings / Revocation of incorporation approval: A court order of bankruptcy due to insolvency, or an administrative disposition resulting from statutory violations.
Voluntary dissolution of a Shadan medical corporation (via general meeting resolution or impossibility of business purpose) strictly requires “approval from the competent prefectural governor.” Unlike a stock company, where liquidation can proceed solely through a shareholders’ resolution and registration, the process typically takes several months from preliminary consultation to obtaining official approval.
Differences in Residual Asset Attribution and Taxation: “With Equity” vs. “Without Equity”
When distributing residual assets upon dissolution, the single most critical factor is the corporation’s legal classification: whether it is a “medical corporation with equity interest” (transitional measure corporation) or a “medical corporation without equity interest” (established after May 2007). The destination of residual assets and the applicable tax regime differ fundamentally.
| Item | Medical Corporation with Equity (Transitional) | Medical Corporation without Equity (Fund-contribution type, etc.) |
|---|---|---|
| Attribution of Residual Assets | Can be distributed to equity holders according to their equity ownership ratio | National government, local governments, other non-equity medical corporations, etc. (Distribution to contributors is strictly prohibited) |
| Return of Contributed Funds (Kikin) | Not applicable (Managed as invested capital) | Can be refunded to contributors up to the original contributed amount (if applicable) |
| Taxation on the Recipient | Amounts exceeding paid-in capital are taxed as “deemed dividends” under comprehensive taxation (progressive rate up to approx. 55%) | Fund return portion is tax-free (no personal income tax as residual assets revert to public bodies/entities) |
| Taxation on the Corporation | Corporate taxes apply to capital gains from asset sales | Liquidation income tax / Corporate tax on asset sale gains |
Important Points on “Deemed Dividend Taxation” for Medical Corporations with Equity
When dissolving a medical corporation with equity and liquidating/distributing accumulated internal reserves (retained earnings), the portion exceeding the initial capital investment is treated as a “deemed dividend” under the Income Tax Act. Unlike standard share transfers (separate self-assessment taxation at approx. 20.315%), deemed dividends are subject to aggregate comprehensive taxation. This means they are combined with other personal income and taxed at progressive rates up to approximately 55% (including local inhabitant tax).
Step-by-Step Liquidation Procedures and Standard Timeline
The dissolution process of a medical corporation typically requires 6 months to 1 year from the initial consultation with the prefecture to the final registration of liquidation completion. Statutory requirements, such as creditor protection procedures, must be strictly fulfilled.
- Decision to Dissolve and Preliminary Consultation with Prefecture (3–6 months prior)
After deciding on the policy at the general meeting of members, conduct preliminary discussions with the medical administration division of the competent local government regarding the statement of reasons for dissolution and the inventory of assets. - Formal Resolution at General Meeting & Appointment of Liquidator
Pass the dissolution resolution and appoint a liquidator (usually the representative director/president in most cases). - Application for Dissolution Approval & Receipt of Approval Certificate
Submit all required documents and obtain formal approval following review by the Prefectural Medical Council. - Registration of Dissolution and Liquidator Appointment (Within 2 weeks of approval)
Complete statutory registration at the Legal Affairs Bureau having jurisdiction over the principal office. - Official Gazette Notice & Individual Notice to Known Creditors
Promptly publish a dissolution notice in the Official Gazette (Kampo) and provide a creditor claim period of at least two months. - Settlement of Debts, Debt Collection & Finalization of Residual Assets
Repay all accounts payable and loans, collect medical fee receivables, and determine/distribute the residual assets. - Approval of Final Accounts & Registration of Liquidation Completion
Prepare the statement of accounts, obtain approval from the general meeting of members, register the completion of liquidation within 2 weeks, and submit the notice of liquidation completion to the governor.
Risks of Forfeiting Licenses, Reimbursement Status, and Inpatient Bed Allocations
When proceeding with dissolution, meticulous attention must be paid to the treatment of licenses and administrative approvals unique to medical institutions.
- Loss of Insurance Medical Institution Designation: Closing the clinic upon dissolution requires submitting a notification of resignation/discontinuation of insurance medical institution designation to the Regional Bureau of Health and Welfare, which terminates the designation.
- Extinguishment of Facility Standards: Approved facility standards and various reimbursement add-on qualifications will simultaneously lapse.
- Regional Medical Care Vision & Surrender of Bed Allocations: For clinics with beds or hospitals, once dissolved and closed, the allocated “permitted hospital bed quota” is surrendered to the prefecture, making it exceptionally difficult to reacquire beds in the same medical zone.
- Settlement of Enterprise Tax Exemption under the Medical Care Act: Tax exemptions applicable to social insurance medical fee revenue must be correctly accounted for in the tax returns of the final liquidation business year.
Economic and Social Comparison: Dissolution/Liquidation vs. Third-Party Succession (M&A)
In recent years, an increasing number of medical corporations facing succession issues are choosing third-party succession (M&A)—either through “equity transfer” (corporations with equity) or “change of members and directors” (corporations without equity)—rather than simple dissolution and liquidation.
Liquidation vs. Third-Party Succession (M&A): Comparison of Pros and Cons
| Item | Dissolution / Liquidation | Third-Party Succession (M&A) |
|---|---|---|
| Founder Proceeds / Net Return | Net proceeds tend to decrease significantly due to deemed dividend taxation (up to ~55%) | For equity transfers, capital gains tax on shares (~20.315% separate taxation) can be applied |
| Continuity of Regional Care | Services cease; patients must be referred elsewhere; bed quotas are lost | Patient care, staff employment, and bed quotas are preserved and seamlessly transferred |
| Administrative Burden | Takes 6–12 months due to prefectural dissolution approval, gazette notices, etc. | Relatively smooth handover via officer change filings and articles amendment approvals |
| Staff Employment | In principle, all staff are dismissed (severance pay obligations apply) | Employment can continue with existing terms as the corporate entity survives |
Self-Assessment Checklist: Deciding Between Liquidation and Succession
When considering the future of a medical corporation, reviewing the following items before initiating dissolution procedures is highly recommended to determine the most rational route for both the entity and the director personally:
- ✅ Confirm Corporation Type: Have you verified the presence of equity interests and residual asset attribution clauses in the Articles of Incorporation?
- ✅ Calculate Retained Earnings and Tax Impact: Have you compared the deemed dividend tax from liquidation against the capital gains tax from an equity transfer?
- ✅ Check Off-Balance Sheet Liabilities & Personal Guarantees: Do you know the exact status of the clinic director’s personal joint guarantees and remaining lease obligations?
- ✅ Assess Impact on Patients and Staff: Have you considered receiving facilities for patients and re-employment options for staff in the event of closure?
- ✅ Strategy for Owned Real Estate/Assets: Have you explored leasing or sales schemes for clinic real estate, including combined clinic-residence properties?
The dissolution of a medical corporation is a complex legal process, and once an approval application is submitted, reversing the procedure becomes difficult. Comprehensive decision-making is essential—taking into account equity valuation, attribution of residual assets, tax minimization, and the potential for practice succession (healthcare M&A). Our specialized advisors provide tailored exit strategies suited to each medical corporation’s specific circumstances. Please feel free to contact us for a confidential consultation regarding dissolution or succession.
Consult M&A Medical for Healthcare Succession
M&A Medical is a specialized M&A and business succession advisory firm dedicated to medical institutions. As a certified M&A support agency accredited by the Small and Medium Enterprise Agency, we support clinic and medical corporation owners—from divestitures due to successor shortages to strategic acquisitions—on a success-fee basis.
- Free initial consultation and preliminary valuation
- No upfront retainer or monthly retainer fees (100% success-fee basis)
- Strict confidentiality guaranteed (executed NDA prior to discussions)
- Full nationwide coverage across all 47 prefectures and all medical specialties
Whether you simply want to understand market valuations, are facing successor challenges, or are exploring joining a medical group, we encourage you to consult us early in your planning stages.